Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/13326
COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines' Side Effects.
Riad, Abanoub | Schünemann, Holger | Attia, Sameh | Peričić, Tina Poklepović | Žuljević, Marija Franka | Jürisson, Mikk | Kalda, Ruth | Lang, Katrin | Morankar, Sudhakar | Yesuf, Elias Ali | Mekhemar, Mohamed | Danso-Appiah, Anthony | Sofi-Mahmudi, Ahmad | Pérez-Gaxiola, Giordano | Dziedzic, Arkadiusz | Apóstolo, João | Cardoso, Daniela | Marc, Janja | Moreno-Casbas, Teresa ISCIII | Wiysonge, Charles Shey | Qaseem, Amir | Gryschek, Anna | Tadić, Ivana | Hussain, Salman | Khan, Mohammed Ahmed | Klugarova, Jitka | Pokorna, Andrea | Koščík, Michal | Klugar, Miloslav
Int. J. Environ. Res. Public Health 2021; 18(15), 7859
Coronavirus disease (COVID-19) vaccine-related side effects have a determinant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally. A multi-country, three-phase study including a cross-sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses' side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population; Results: The study protocol has been registered at ClinicalTrials.gov, with the identifier NCT04834869. CoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines.
COVID-19 | Cohort studies | Cross-sectional studies | Drug-related side effects and adverse reactions | Health personnel | Mass vaccination | Prevalence
COVID-19 | Vaccines | COVID-19 Vaccines | Cross-Sectional Studies | Humans | Prospective Studies | SARS-CoV-2 | Watchful Waiting